Empery Asset Management, LP Sellas Life Sciences Group, Inc. Transaction History
Empery Asset Management, LP
- $16.8 Million
- Q3 2022
A detailed history of Empery Asset Management, LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 308,466 shares of SLS stock, worth $360,905. This represents 3.71% of its overall portfolio holdings.
Number of Shares
308,466
Previous 927,984
66.76%
Holding current value
$360,905
Previous $2.07 Million
69.89%
% of portfolio
3.71%
Previous 11.2%
Shares
2 transactions
Others Institutions Holding SLS
# of Institutions
35Shares Held
8.03MCall Options Held
2.52MPut Options Held
24.7K-
Anson Funds Management LP Dallas, TX4.83MShares$5.65 Million0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.77 Million0.0% of portfolio
-
Black Rock Inc. New York, NY278KShares$325,5150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA273KShares$319,4830.0% of portfolio
-
Opus Capital Group, LLC201KShares$234,7020.03% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $24M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...